SYF29d4cf1bbd6b498fb199a5d329daba40Registry ID: 2024-518646-24-00|Not Yet Recruiting
Loading search results
interventional
N/A
1 country
1
To assess that the efficacy of fosfomycin calcium in the clinical and microbiological resolution of the uUTI in womwn is non-inferior to the efficacy of fosfomycin trometamol
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 20, 2024
Actual (reported)Clinical (resolution of symptoms of uUTI) and microbiological response (bacterial pathogen reduced to <1000 CFU/mL in urine culture) in the microbiological -ITT population obtained at TOC VISIT
Proportion of subjects with continued clinical and microbiologic success assessed at Visit 1 (TOC visit)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hospital Universitario Araba
Vitoria, 01009, Spain
María Cabero
First Submitted
November 20, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.